California
Dec 24, 2015
One of the biotech companies run by Martin Shkreli, the reviled drug price-gouger charged with securities fraud last week, was informed Wednesday that its stock will be delisted by Nasdaq because of Shkreli’s arrest and other issues. Meanwhile, KaloBios Pharmaceuticals Inc. also is dealing with the abrupt resignation of its accounting firm and a void left by its firing of...
California
Dec 21, 2015